{{Rsnum
|rsid=2297381
|Gene=RPAP1
|Chromosome=15
|position=41535457
|Orientation=plus
|GMAF=0.405
|Gene_s=RPAP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 25.7 | 38.1 | 36.3
| HCB | 22.1 | 51.5 | 26.5
| JPT | 20.4 | 49.6 | 30.1
| YRI | 74.0 | 24.7 | 1.4
| ASW | 59.6 | 40.4 | 0.0
| CHB | 22.1 | 51.5 | 26.5
| CHD | 32.1 | 55.0 | 12.8
| GIH | 24.8 | 55.4 | 19.8
| LWK | 71.3 | 25.9 | 2.8
| MEX | 37.9 | 39.7 | 22.4
| MKK | 48.7 | 42.3 | 9.0
| TSI | 25.5 | 45.1 | 29.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22258532
|Title=A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}